Labopharm Inc.
Records under this name other than patents Labopharm Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,829,120 | Trazodone composition for once a day administration Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 8,487,002 | Controlled-release compositions Formerly held In force · High confidence | In force | High confidence | |
| US 9,090,649 | Oligonucleotide Duplexes Comprising DNA-Like and RNA-Like Nucleotides and Uses Thereof Formerly held In force · High confidence | In force | High confidence | |
| US 9,719,091 | Oligonucleotide Duplexes Comprising DNA-Like and RNA-Like Nucleotides and Uses Thereof Formerly held In force · High confidence | In force | High confidence | |
| US 9,439,866 | Trazodone composition for once a day administration Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 8,486,448 | Misuse Preventative, Controlled Release Formulation Formerly held In force · High confidence | In force | High confidence | |
| US 8,486,449 | Misuse Preventative, Controlled Release Formulation Formerly held In force · High confidence | In force | High confidence | |
| US 8,795,723 | Sustained drug release compositions Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 8,895,066 | Bilayer Composition for the Sustained Release of Acetaminophen and Tramadol Formerly held In force · High confidence | In force | High confidence | |
| US 8,414,919 | Sustained drug release composition Formerly held In force Term ended Oct 9, 2026 · From the USPTO record | In force | Term ended Oct 9, 2026 | From the USPTO record |